.
Our Science
Clinical Trials
About KalVista
Information Center
See New England Journal of Medicine publication of Phase 3 data for oral sebetralstat for the on-demand treatment of HAE view NEJM
Learn more
Sebetralstat
mechanism of action
Sebetralstat, our on-demand HAE product candidate
KalVista’s pipeline
Our publications & posters
For healthcare professionals
contact us at medinfo@Kalvista.com
Return
Learn more about the
Konfident-S extension study.
Learn more about
the KONFIDENT Study.
Access our Medical Affairs information
or contact us at medinfo@Kalvista.com
Return
Return
Return
Return
Return

About KalVista

At KalVista, our scientific advances in orally-delivered, small molecule medicines are designed to change the treatment landscape to make a meaningful difference for people living with HAE. Our growing team of talented people and deep scientific expertise in the Kallikrein-Kinin System keep us united in our determination to innovate. We have our sights set on elevating the standard of care for patients with HAE and other chronic diseases.

Information Center

KalVista Resources

KalVista website: www.kalvista.com

HAE attack educational website: www.mindtheHAEattack.com

Medical information inquiries: medinfo@kalvista.com

General inquiries: info@kalvista.com

Welcome to the Kalvista Virtual Booth.

Please click the button below to continue.

This information is intended for US Healthcare Professionals only.

Continue

This experience requires landscape orientation.